LOQUS23 THERAPEUTICS

LoQus23 is a DDF-formed company focussing on targeting DNA damage repair pathways to treat Huntington’s disease and other triplet repeat diseases.

http://loqus23.com

https://linkedin.com/company/loqus23-therapeutics-ltd

David Reynolds

CEO and Co-Founder

Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.